Kathmandu. Sopan Pharmaceuticals Limited has opened the initial public offering (IPO) to Nepalese working abroad from March 9.
Out of the total 42,90,000 units of shares, 10% i.e. 4,29,000 units have been allotted to the Nepalese living abroad in the first phase. Applications can be place for minimum 10 units and maximum 11,000 units from March 28. If the full application is not received within this period, the deadline will be extended until April 23.
NMB Capital Limited is the issue manager for the IPO and can apply for the shares online or through C-ASBA member banks and financial institutions. Care Ratings Nepal has assigned a rating of “CareNP B” to the company, indicating that the investment is highly risky.
Out of the total offered shares, 5% has been set aside for mutual funds and 4% for employees of the company and the remaining 3,474,900 units will be issued to the general public.
Leave your comment